-
Jun 14, 2021, 3:20 pm77 ptsThe U.S. is likely soon to have a fourth vaccine approved for the fight against COVID-19. Novavax just released the results of its Phase 3 clinical trial: Its two-dose vaccine demonstrates 90 percent overall efficacy and 100 percent protection against both moderate and severe COVID-19 disease. The…
Welcome to Politomix -- the political news wire where left, right and center mix.
Politomix aggregates the day's political news on the web and your mobile device.